Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02055105 · ClinicalTrials.gov registry record
Modulation of Molecular Fingerprinting in Pediatric Sepsis
A clinical trial of Systemic Inflammatory Response Syndrome, sponsored by Phoenix Children's Hospital.
- Recruiting
- Registry status
- 50
- Enrollment target
- 2
- Study locations
NCT02055105: Recruiting study of Systemic Inflammatory Response Syndrome, sponsored by Phoenix Children's Hospital.
NCT02055105 is a study of Systemic Inflammatory Response Syndrome that is actively recruiting participants, run by Phoenix Children's Hospital. The registered enrollment target is 50 participants, below the 588-participant average among 5 other Systemic Inflammatory Response Syndrome trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02055105, a study of Systemic Inflammatory Response Syndrome, is actively recruiting participants, sponsored by Phoenix Children's Hospital.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to demonstrate the sensitivity and specificity of detecting circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow expression and modulation of levels in response to therapy in comparison to current biomarkers.
Primary Outcome
Will compare PRISM 3 scores from baseline to hospital discharge.
Conditions Studied
Interventions
- PROCEDURE miRNA in Sepsis
Study Locations (2)
Arizona
- Phoenix Children's Hospital - Phoenix
- Phoenix Children's Hospital - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-03 |
| Est. Completion | 2027-10 |
What NCT02055105 shows while recruiting
NCT02055105 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 588-participant average among 5 other Systemic Inflammatory Response Syndrome trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Systemic Inflammatory Response Syndrome appearing as the primary indexed condition, and to 1 intervention - of which miRNA in Sepsis is the first listed.
NCT02055105 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT02055105 about?
NCT02055105 is a clinical study titled "Modulation of Molecular Fingerprinting in Pediatric Sepsis". The goal of this study is to demonstrate the sensitivity and specificity of detecting circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow expression and modulation of levels in response to therapy in comparison to current biomarkers.
What is the current status of trial NCT02055105?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2014-03. Estimated completion is 2027-10.
What conditions does trial NCT02055105 study?
This clinical trial studies the following conditions: Systemic Inflammatory Response Syndrome.
What interventions are being tested in trial NCT02055105?
The interventions under investigation include: miRNA in Sepsis (PROCEDURE).
Who is sponsoring clinical trial NCT02055105?
This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02055105 being conducted?
This trial has 2 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systemic Inflammatory Response Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
RECRUITING · Phase 4
-
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
RECRUITING
-
A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS
COMPLETED · Phase 2
-
Feeding the Critically Ill During Phases of Altered Redox Status
COMPLETED · NA
-
Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia